Oppenheimer & CO Inc Seres Therapeutics, Inc. Transaction History

Oppenheimer & CO Inc

  • $5.91 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023
BUY
$2.33 - $5.07 $6,440 - $14,013
2,764 Added 7.12%
41,583 $98,000
Q2 2023

Aug 02, 2023
BUY
$4.67 - $6.55 $7,976 - $11,187
1,708 Added 4.6%
38,819 $185,000
Q1 2023

May 10, 2023
BUY
$4.95 - $6.09 $183,699 - $226,005
37,111 New
37,111 $210,000

Others Institutions Holding MCRB

# of Institutions
100
Shares Held
62.7M
Call Options Held
36.9K
Put Options Held
476K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email